ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00251797
Recruitment Status : Completed
First Posted : November 10, 2005
Last Update Posted : January 7, 2010
Sponsor:
Information provided by:
University of New Mexico

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : June 2006